Aisling Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-342,815
| Closed | -$16.7M | – | 20 |
|
|
2022
Q1 | $16.7M | Sell |
342,815
-12,600
| -4% | -$613K | 9% | 4 |
|
|
2021
Q4 | $15.2M | Sell |
355,415
-237,400
| -40% | -$10.1M | 5.35% | 6 |
|
|
2021
Q3 | $22.7M | Sell |
592,815
-250,000
| -30% | -$9.58M | 4.53% | 4 |
|
|
2021
Q2 | $23.8M | Hold |
842,815
| – | – | 3.81% | 4 |
|
|
2021
Q1 | $27.8M | Hold |
842,815
| – | – | 5.01% | 2 |
|
|
2020
Q4 | $30.5M | Hold |
842,815
| – | – | 5.23% | 3 |
|
|
2020
Q3 | $28.6M | Buy |
+842,815
| New | +$28.6M | 9.13% | 3 |
|